12 IPOs raised $3.7 billion this past week, led by software maker UiPath (PATH), which raised more than $1 billion in its public debut. The pipeline remained active, with 11 IPOs and one direct listing submitting initial filings. SPAC activity...read more
Rain Therapeutics, a Phase 3-ready biotech developing in-licensed therapies for cancer, raised $125 million by offering 7.4 million shares at $17, the midpoint of the range of $16 to $18. At pricing, the company commands a fully diluted market value of $457...read more
Rain Therapeutics, a Phase 3-ready biotech developing in-licensed therapies for cancer, announced terms for its IPO on Monday. The Newark, CA-based company plans to raise $125 million by offering 7.4 million shares at a price range of $16 to $18. At the...read more
Updated Monday, 4/19. 11 IPOs are scheduled to raise a total of $3.6 billion in the week ahead, led by software maker UiPath (PATH). The largest IPO of the week, UiPath (PATH) plans to raise $990 million...read more
US IPO Weekly Recap: UiPath’s billion-dollar deal leads a 12 IPO Week
12 IPOs raised $3.7 billion this past week, led by software maker UiPath (PATH), which raised more than $1 billion in its public debut. The pipeline remained active, with 11 IPOs and one direct listing submitting initial filings. SPAC activity...read more
Oncology biotech Rain Therapeutics prices IPO at $17 midpoint
Rain Therapeutics, a Phase 3-ready biotech developing in-licensed therapies for cancer, raised $125 million by offering 7.4 million shares at $17, the midpoint of the range of $16 to $18. At pricing, the company commands a fully diluted market value of $457...read more
Oncology biotech Rain Therapeutics sets terms for $125 million IPO
Rain Therapeutics, a Phase 3-ready biotech developing in-licensed therapies for cancer, announced terms for its IPO on Monday. The Newark, CA-based company plans to raise $125 million by offering 7.4 million shares at a price range of $16 to $18. At the...read more
US IPO Week Ahead: Software, synthetic biology, and more in an 11 IPO week
Updated Monday, 4/19. 11 IPOs are scheduled to raise a total of $3.6 billion in the week ahead, led by software maker UiPath (PATH). The largest IPO of the week, UiPath (PATH) plans to raise $990 million...read more